SC-77964

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameSC-77964

Drug Alias NameSC-964

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase inhibitorsAngiogenesis inhibitors

TargetsMatrix metalloproteinase

Therapy Area/IndicationsOsteoarthritisNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsOsteoarthritisNeoplasms

ATC CodeN/A